NEW YORK (GenomeWeb) – GMSbiotech and Pure Protein announced today that they have received a $2.6 million grant from the National Institutes of Health to develop a donor-specific antibody (DSA) diagnostic for use in organ transplant patients.

The companies will combine GMSbiotech's proprietary microarray platform with soluble human leukocyte antigen proteins produced by Pure Protein. The resulting assay will be designed to analyze patients' DSA levels for the detection of antibody-mediated rejection of transplants.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.

Mar
08
Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.

Apr
03
Sponsored by
Dovetail Genomics

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.